SCHEMBL23337970

SCHEMBL23337970

FC(F)(F)c1cnc(Nc2cc(Cl)nnc2Cl)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 1/20 0.48
▸ ALDH1A1 P00352 7/20 0.47
▸ GAA P10253 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPT P10636 3/20 0.45
▸ TSHR P16473 1/20 0.45
▸ NR4A1 P22736 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ HTT P42858 3/20 0.43
▸ POLB P06746 2/20 0.43
▸ NOD2 Q9HC29 1/20 0.43
▸ JAK2 O60674 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ MC4R P32245 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23337964 0.78 ALDH1A1 (0.45) FGFR4ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL23337972 0.77 TRPV1 (0.42) ALDH1A1GAASMN1; SMN2MAPTMEN1
SCHEMBL23337969 0.76 ALDH1A1 (0.46) FGFR4ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL8635254 0.74 ALDH1A1 (0.51) FGFR4ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL23337967 0.74 IRAK4 (0.41) —
SCHEMBL9362813 0.73 MAPT (0.50) FGFR4ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL8989531 0.73 ALDH1A1 (0.58) ALDH1A1GAASMN1; SMN2MAPTKDM4E
SCHEMBL11819244 0.73 JUN (0.41) ALDH1A1GAAMAPTKDM4EL3MBTL1
SCHEMBL17154863 0.72 MAPT (0.61) FGFR4ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL23337963 0.72 IRAK4 (0.35) TDP1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210337797-A1 PREPARATION OF PYRIDAZINYL AMINE COMPOUND AND APPLICATION THEREOF Synwill Co., Ltd. (CN) 2021-11-04 — — US disclosed
EP-3854791-A1 PREPARATION OF PYRIDAZINYL AMINE COMPOUND AND APPLICATION THEREOF Synwill Co., Ltd. (CN) 2021-07-28 — — EP disclosed
WO-2021081923-A1 2-PYRIDYLAMINE DERIVATIVE USED AS FUNGICIDE 江苏中旗科技股份有限公司 2021-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210337797-A1 PREPARATION OF PYRIDAZINYL AMINE COMPOUND AND APPLICATION THEREOF ACHE, EML4, TOP2A FGFR4 3887/4885ALDH1A1 2266/4885GAA 2616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback